Renal Dialysis-related Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Renal Dialysis-related Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2018-03-27EMA Lapsed: Tasermity (sevelamer hydrochloride) — Genzyme Europe BV
EMA has lapsed the marketing authorization for Tasermity (sevelamer hydrochloride) by Genzyme Europe BV for hyperphosphatemia and renal dial…